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I. INTRODUCTION
Arenavirus is the proposed designation for a set of viruses which have a unique
morphology (76). The virions are round, oval, or pleomorphic with diameters be-
tween 60 and 350 nm, an electron-dense membrane with spikes or projections, and a
number ofinclusion-like, dense particles that give the virion an aspect ofhaving been
sand sprinkled (arenosus). Arenaviruses have an RNA genome, are inactivated by
lipid solvents, and share antigenic components. Since the first recognized member of
this group was lymphocytic choriomeningitis (LCM) virus, it is considered the pro-
totype.
II. HISTORICAL BACKGROUND
LCM virus has been known since 1934 and soon after it was etiologically
associated with a disease syndrome of man, acute benign aseptic meningitis. Ta-
caribe virus, isolated from bats in Trinidad in 1956 and first described in 1963, has
not been associated with human disease (23). The next virus to be isolated and
characterized was Junin virus, in 1958; the virus was isolated from patients with Ar-
gentinian hemorrhagic fever (AHF). Five years later another virus, Machupo, was
isolated from a fatal case of an illness, Bolivian hemorrhagic fever (BHF), clinically
very similar to AHF. Other viruses, antigenically placed in theTacaribegroup, were
discovered soon after: Amapari in Brazil, 1964 (71), Latino in Bolivia (93), Parana in
Paraguay (92), Pichinde in Colombia (88), and Tamiami in USA (16), in 1965. None
of these five is known to cause human illness. The last member of the group, Lassa
virus, was recovered from patients suffering from a severe disease first seen in Ni-
geria.
A serological relationship among members of this set was first observed between
Junin and Tacaribe viruses in 1963, resulting in the creation of the Tacaribe anti-
genic group (57); the other viruses, except LCM and Lassa, were easily shown to be
related to Tacaribe and Junin and placed in the group. The similarity ofmorphology
and morphogenesis between LCM and the Tacaribe group viruses was noted in 1969
(62) and soon after it was shown that there was an antigenic connection between
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them (77). Finally, it was observed in 1970 that Lassavirus was antigenically related
to LCM and to some oftheTacaribegroup agents (15) and that its morphology con-
formed to that described for LCM (86).
III. METHODOLOGY
A. Mortality
The case fatality rate of some members of this group is sufficiently high that
deaths from the disease gives a good idea ofthe morbidity rateprovided an accurate
diagnosis can be made. For example, the mortality from Lassa fever ranges from
30-60%, Argentine hemorrhagic fever 3-15%, and Bolivian hemorrhagic fever 5-
30%. However, deaths from lymphocytic choriomeningitis are rare. For the most
part these diseases are rare, limited to localized outbreaks, and confined to a very
few geographic areas. For those reasons, the official mortality records would be un-
likely to reflect their occurrence in a country.
B. Morbidity
Epidemiological studies on arenavirus infections of man are hindered by the fact
that disease reporting is uncertain and incomplete. The diagnosis of sporadic cases
ofLCM is, most likely, not made or isguesswork in nearly all instances, unless labo-
ratory aid is sought. Diagnosis of AHF in the area and season where the disease is
anticipated is confirmed by laboratory studies in about 70% of clinically diagnosed
cases (54, 49); how many clinically undiagnosed infections go undetected is not
known. It is doubtful whether an effective reporting system has been devised and im-
plemented for these diseases, with the possible exception of AHF. Owing to the
highly specialized type of diagnostic work required for identification of the viruses
and antibodies resulting from infection, and due to the risk associated with certain
aspects of the laboratory procedures, the knowledge of the prevalence of the infec-
tions and illnesses caused by the arenaviruses is limited.
C. SerologicalSurveys
Due to the difference in duration ofdifferent antibodies, seroepidemiological sur-
veys are carried out mainly by means of the neutralization test (14, 34, 40) even
though this is a more cumbersome test than comnplement fixation; it should benoted
that not many extensive surveys have been carried out, except with LCM virus. The
complement-fixation test is extremely useful as an aid to the diagnosis of a recent
illness; the fact that it is less type specific than the neutralization test, to the point
that it hardly differentiates between Junin and Machupo viruses infections of man
(95), does not detract from its value due to the limited geographic distribution of
theseviruses.
D. Laboratory Diagnosis
While a clinical diagnosis of fully developed, typical cases of AHF and BHF can
be made with considerable accuracy in the districts where the diseases are endemic
at the time ofyear when they prevail, particularly if several similar cases appear si-
multaneously, it is most doubtful whether a sporadic case ofLCM can be accurately
diagnosed. A presumptive diagnosis of Lassa fever can be entertained in known en-
demic areas by experienced physicians faced with a severe or moderately severe case
(59).
A specific diagnosis of these illnesses requires that either the virus be isolated and
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identified from the patient's blood, excretions, or secretions, usually early during the
disease; or that development of specific antibodies is shown to occur late in the
disease or in convalescence.
The complement-fixation (CF) test has been most useful as a diagnostic aid with
these illnesses; it is not, however, an early means of diagnosis since from 15 to 30
days from onset are required for it to become positive with most patients, perhaps a
shorter time with LCM. The CF is not a specific test within the arenaviruses, cer-
tainly not between Machupo and Junin viruses (95, 47); but since theseviruses occur
in different areas a diagnostic error between the two is unlikely to occur. On the
other hand, difficulties in the interpretation of CF results have arisen in an area
where Junin and LCM viruses have infected man, simultaneously or sequentially
(49, 50). In fact, in view of the known wide distribution of LCM virus, it is con-
ceivable that diagnostic problems may arise when the CF test is used to diagnose
Machupo or, ifin Africa and if LCM virus is there, with Lassa viruses. Since LCM
virus occurs in many European countries, introduction of an exotic arenavirus in
that continent might result in diagnostic difficulties ifthe CF test alone were used.
The fluorescent antibody technique (FAT) has been used advantageously for an
early diagnosis of LCM virus infection of man (7, 25). The neutralization test has
been used less for diagnosis of current illnesses and serological surveys-LCM ex-
cepted-than for characterization of the viruses themselves; as will be seen in
another section, it is sharply specific (93).
IV. THE VIRUSES
A. Biochemical andPhysical Properties
The most extensive studies to determine biochemical and physical properties of
the arenaviruses have been done with LCM (69) and Pichinde (74). The picture that
emerges from these studies and from less complete investigations of the other
viruses in thegroup is one ofremarkable uniformity.
Through the use of various drugs that inhibit nucleic acid synthesis in infected
cells in cultures, it has been indirectly shown that all arenaviruses with the ex-
ception of Tacaribe, for which no studies appear to have been reported contain
RNA; compounds which preferentially inhibit DNA synthesis such as halodeoxy-
uridines (BUDR, FUDR), have no inhibitory effect on theseviruses.
Studies with LCM and Pichinde viruses have directly shown the presence of
single-stranded RNA in the virion. Analysis of the RNA by zonal centrifugation in
5-20% sucrose gradients and by electrophoresis in acrylamide gels showed, with
each virus, the presence offive components of molecules with sedimentation values
of 31S, 28S, 23S, (22S for Pichinde), 18S, and 4-6S. It has been concluded that, for
both viruses, the 31S and 23 (or 22)S RNA's were virus specific; the 28S and 18S
RNA's which account for 25-50% of the labeled RNA in the LCM virion, repre-
sented ribosomes from the host cell located inside the virion; and the 4-6S
components were also from host cell origin (69, 74).
The base composition ofthe viral RNA was found to differ markedly from that of
the host cells RNA. The RNA responsible for viral coded products would be about
3.2 x 106 daltons, with Pichinde virus (74).
Analysis oftheviral proteins by electrophoresis in acrylamidegels has revealed, in
Pichinde virus, the presence of four polypeptides coded for by the virus and incor-
porated in the virion; two of these are glycopolypeptides. A polypeptide and a
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glycopolypeptide, both with molecular weights about 72,000 daltons, appear to be
associated with the viral nucleic acid functioning as nucleoproteins; the other
glycopolypeptide, molecular weight about 34,000 daltons, is an envelope constituent;
and the second polypeptide, with a molecular weight of 12,000 daltons, has no
assigned function (74).
Buoyant density in sucrose gradients has been reported as 1.17 or 1.18 g/ml for
LCM, Pichinde, Machupo, Junin, Tacaribe, and Amapari and between 1.18 and 1.2
g/ml for Parana virus in cesium chloride. A noninfectious CF antigen produced by
these viruses has a buoyant density between 1.09 and 1.11 g/ml (40).
All arenaviruses are easily inactivated by ethyl ether, chloroform, and sodium
deoxycholate. Thermal inactivation of LCM virus is accelerated by the presence of
divalent cations in the suspending medium. The effect of betapropiolactone on Lassa
virus has been reported; the virus infectivity is completely inactivated with a concen-
tration of the drug between 0.1 and 0.15% with preservation of complement-fixing
activity (15).
B. Morphology and Morphogenesis
The similarities in morphology and morphogenesis are so marked and distinctive
that they were the basis for first associating the viruses in the present taxon (62, 76).
Thin-section electron microscopy of Vero cells infected with all 10 arenaviruses
show them to be indistinguishable from each other. Coinciding with the highest in-
fectious titers of the inoculated cultures there is a large number of particles seen in
the cultures. The particles are round, oval, or pleomorphic, 60-280 nm in diameter,
have a membranous envelope with surface projections or spikes approximately 6 nm
long, and contain a variable number from 2-10, internal electron-dense granules,
about 20 nm in diameter, strongly resembling ribosomes. No symmetry has been
discerned with any ofthese viruses (63, 64).
The particles mature by budding from plasma membranes. Vero cells infected
with each of the viruses contain distinctive intracytoplasmic inclusion bodies,
consisting of a smooth matrix in which are embedded dense granules similar to
those seen in the virions and indistinguishable from the host cell ribosomes. These
inclusion bodies seem to match in size and location the cytoplasmic inclusions ob-
served under light microscopy in cells infected with the viruses (63, 64).
Negative-contrast electron microscopy of virus particles sedimented from
infected cell cultures has been reported with these viruses except Junin, Machupo,
and Lassa; technical or hazard considerations prevented their study. The results
with the remaining arenaviruses have, again, shown decided uniformity of the
viruses, with pleomorphic particles slightly larger than in thin sections, from 90-350
nm, pronounced surface projections, and no resolution ofinternal structure (64).
Electron microscopy studies of whole animals infected with arenaviruses (64)
have revealed the presence of particles similar to those described above in a number
of tissues of Calomys callosus infected as newborn with Machupo and Latino
viruses. No such particles have been seen in hamsters infected with Junin virus and
only few in the salivary gland tissue of mice infected with Tacaribe virus. In general,
only occasional virus particles have been observed in the brain tissue of mice infected
with LCM, Tacaribe, Lassa, or Tamiami viruses, while parallel studies indicate the
presence ofspecific antigen.
The particles associated with arenavirus infection of cells in culture have been
shown to contain specific antigen material by labeling procedures, at least with
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LCM virus; whether all size particles are equally infectious cannot be decided by
electron microscopy alone (53). Estimates of infectious size particles by centrifu-
gation or filtration have given sizes between 37 and 60 nm for LCM virus (43); by
filtration, between 70 and 140 nm for Lassa virus (15).
C. Antigenic Properties
Early studies with LCM virus demonstrated the existence ofa CF antigen distinct
and separable from the infective particle by centrifugation; it was designated soluble
antigen. The nature and properties of this antigen has been the subject of recent
studies (33) which confirm that virion and CF antigen are distinct entities. The latter
on inoculation to experimental animals induces formation of antibodies which react
in vitro with the CF antigen but will not neutralize the virion; furthermore, repeated
inoculations of CF antigen fail to induce any protection against subsequent
challenge ofguinea pigs. It appears that the CF antigen is not present on the surface
of the virion; it has not been determined whether it is a structural component of the
virion.
The humoral immune response with arenaviruses has certain characteristics
mainly observed with LCM virus, but which may also appear with other agents: CF
and neutralizing antibodies and antibodies detected by the fluorescent antibody tech-
nique (FAT) seem to be independent (35). CF antibodies against LCM in man ap-
pear relatively early in the disease, from 8 days to 2 mo; neutralizing antibodies are
found later, usually not before 2 mo after onset, and FAT antibodies may be de-
tected earlier than CF antibodies (35). It is easy to prepare immune sera in mice with
Pichinde or Lassa viruses, which react with good titers by CF test; the same sera
may have little neutralizing capacity when tested in a mouse neutralization test (88)
or in a plaque-reduction test (15, 59).
Antigenic relationship among arenaviruses has been mainly detected by the CF
test. Table 1 is a composite table incorporating results from several sources and it is
an attempt to illustrate the relative position of the viruses in the taxon. Tacaribe,
Junin, Machupo, Amapari, Parana, and Latino viruses are very closely related by
TABLE 1
Complement-Fixation Test with Arenavirusesa
Serum
JUN TCR
Antigen MAC Ser. 1 Ser. 2 Ser. 1 Ser. 2 AMA LAT PAR PIC TAM LAS LCM
Machupo 128 64 128 64 32 0
Junin 64 256 16 256 64 64 32 0 4 8
Tacaribe 64 64 512 32 32 32 0 4 8
Amapari 64 32 64 128 32 32 8 4 4
Latino 32 32 8 8 256 16 8 0
Parana 32 16 8 16 16 512 16 0
Pichinde 4 64 256 4 0
Tamiami 32 8 8 32 0 32 64 128 0
Lassa 0 0 0 0 256 4
LCM 0 0 4 4 16 256
aComposite table derived from various authors.
Reciprocal of serum titers; 0, no fixation at dilution 1:4 or 1:8.
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CF with mouse hyperimmune sera; the available fragmentary evidence shows that
Pichinde and Tamiami viruses are not closely related to the others nor to each other.
LCM and Lassa viruses are very distantly related to the other agents; only when
using the highest titered antisera can cross reactions be observed.
Results of neutralization tests, many of them done with samples of the same sera
that showed markedly crossing by CF, are markedly specific. In comprehensive
plaque-reduction tests (16, 37, 93) in which sera had homologous titers in the range
from 1:32 to 1:2048, generally 1:128-1:5 12, no cross neutralizations have been noted
even between viruses which are very close by CF, such as Machupo, Tacaribe, and
Junin. The same marked specificity has been observed when constant serum was
used with varying dilutions of virus. Studies with LCM and Lassa viruses are less ex-
tensive but they also show marked specificity in the N test.
Investigations with the FAT, especially the indirect rest, show this technique to be
less specific than the neutralization test; in fact it was with this method that the
serological association between LCM and the Tacaribe group viruses was first ob-
served (77). Antisera to all members of the Tacaribe group reacted with LCM virus;
LCM antisera reacted with Amapari virus but little with Tacaribe. Cross-reactions
have also been observed between Lassa and LCM viruses (15) and between Latino
antiserum and Pichinde antigen (93).
D. Biological Properties
The natural hosts and reservoirs of the arenaviruses that cause human disease are
discussed in the corresponding sections. The remaining viruses have been isolated in
nature from the following animals: Tacaribe from Artibeus bats; Amapari from
Oryzomys and Neacomys rats; Pichinde from Oryzomys and Thomasomys; Parana
from Oryzomys; Latino from Calomys; and Tamiami from Sigmodon (cotton rat)
and Oryzomys. Attempts to isolate these viruses from other natural hosts, including
arthropods, have been reported, largely with negative results: Pichinde virus has
been isolated from ectoparasites taken offviremic hosts; Amapari has been isolated
from mites (Gamasidae); Tacaribe was reported to have been isolated from a mixed
mosquito pool.
Among experimental hosts, 1- to 4-day-old mice develop fatal illness after in-
tracerebral inoculation of most, but not all, arenaviruses. Latino virus does not
infect mice, and Parana inoculation results in illness but no death; LCM virus
strains, in general, are lethal when inoculated to young adult mice but not to
newborn mice. Newborn hamsters are lethally infected by Junin, Latino, Machupo,
Parana, and Pichinde viruses; guinea pigs are susceptible to LCM and Junin viruses.
All arenaviruses, except LCM, replicate with production of plaques under agar
overlay in Vero cell monolayers; some have marked cytopathic effect (CPE) in cells
in fluid cultures. Other cells, LLCMK2 and HeLa, are susceptible to some of the
viruses with CPE development. LCM virus multiplies reaching high titers in nearly
all cells in culture that have been tried but CPE, including plaque formation, is not a
feature of the multiplication of this virus, except in rare circumstances and par-
ticular systems (70).
A special property of arenaviruses that cause disease of man, repeatedly
described with LCM and Machupo, is their capacity to induce persistent tolerant
infection in their natural hosts with no ill effects to the host and in the absence of an
immune response; the epidemiological implications of this fact are evident.
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V. PATHOGENESIS AND IMMUNITY
LCM virus infection of the adult mouse is the classical example ofvirus-induced
immunopathological disease. Intracerebral inoculation ofthe adult mouse results in
manifest disease and death while infection before or soon after birth leads to a
nonpathogenic lifelong carrier state. In the neonatal mouse during the period ofim-
munological immaturity the virus does not stimulate an immune response; since the
virus is, presumably, harmless for the mouse, no ill effects result. In the adult mouse
which has reached immunological maturity, the virus incorporated in the cells
stimulates an immune response from the host; it is this conflict between the host and
the virus which results in disease, a fatal choriomeningitis with no evidence of
neuronal destruction. Numerous observations (35, 43) by many workers have firmly
established the above pathogenetic mechanism for the disease; it is, furthermore,
observed that immunosuppressants protect adult mice against death due to LCM
virus infection. Since among the immunosuppressing treatments, antilymphocytic
serum and neonatal thymectomy are effective, it appears that the immune disease is
cell mediated rather than caused by antibodies.
Studies with Tamiami virus (32) showed that suckling mice after intracerebral
inoculation of the virus develop an acute CNS disease with cerebellar ataxia and less
frequently paralysis, convulsions, and death. Neonatal thymectomy totally pre-
vented the disease in spite of the presence ofvirus in high titer in the brain tissue; it
was suggested that the acute disease caused by the virus is immunomediated.
With the present state of knowledge no definite statement can be made con-
cerning the mechanism through which the arenaviruses cause disease in man. There
is nothing to indicate that lesions and disease are immunopathological or allergic
phenomena, as is so clearly the case in adult mice infected with LCM virus; clinical
and pathological observations rather favor the view that direct damage to cells by
the virus best explain the disease.
Little is known about the type and localization oflesions in man after LCM virus
infection and about the multiplication and distribution of the virus, duration of vi-
remia, and persistence ofantibodies. With other arenaviruses, autopsy of 10 patients
who died of AHF consistently revealed generalized lymphadenopathy on gross
examination; microscopically, endothelial swelling in capillaries and arterioles ofall
organs examined was seen without exception and lymphocyte depletion in the spleen
was generally observed (30). In another series (24) it was stressed that lesions in
several organs and tissues were probably caused by direct cytotoxic action of the
virus on cells, in the absence of conspicuous cellular infiltration. In connection with
the diffuse involvement ofcapillary and arteriolar endothelium (30) it is ofinterest to
mention that disseminated intravascular coagulation has been described in one case
ofAHF and suggested as a pathogenetic factor in the disease (5).
The result of a liver biopsy in a fatal case of Lassa fever is highly pertinent to the
pathogenesis of the disease (96). Diffuse hepatocellular damage was evident, with
focal necroses; by electron microscopy was observed a clear association between
damaged liver cells and virus particle formation and maturation, while inflamma-
tory response was minimal. These findings suggested that a direct cytopathic effect
was responsible for, at least, the hepatic lesions in Lassa fever and that cell-
mediated or humoral immunologic damage is not a major factor.
The most constantly reported lesion in AHF, probably also in BHF, is a diffuse
swelling of the endothelium of capillaries and arterioles in the absence ofinflamma-
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tory reaction; clinically, there is in nearly all patients an adenopathy, local or
generalized; there is also leukopenia, late appearance ofantibodies, and the fact that
recovery occurs at the time when antibodies begin to build up; biphasic patterns of
clinical disease are all but unknown with AHF and BHF. Finally, cell damage, when
it occurs in specific organs, appears to be associated with a direct cytopathic action
of the virus on the cell, with no cellular infiltration. Based on these observations, the
following pathogenesis has been suggested (40) for arenavirus infections of man: the
virus gains entry by the upper respiratory or alimentary route, is caught in the local
lymphoid tissue or lymph nodes where it first replicates; it then invades the cells of
the reticuloendothelical system including all the cells involved in the immune and
cellular immune responses, whose functions are, therefore, inhibited at this time.
The virus causes, directly or indirectly, extensive capillary damage resulting in
capillary fragility, hemorrhagic tendency, and hypovolemic shock; malfunction of
the various organs is due probably to capillary damage and edema of the pa-
renchyma rather than actual cell damage. When the disease regresses, no per-
manent damage ensues, since there has been little cell damage; antibodies develop to
a high titer. In progressive cases, a direct cytopathic action of the virus on the cells
follows; coagulopathy can occur but immunopathology is at no time evident.
After overt infection of man with arenaviruses, antibodies develop which have
been detected by complement-fixation and neutralization tests and, recently, by the
fluorescent-antibody technique; no hemagglutination-inhibition test is available for
these viruses. With LCM, AHF, and BHF complement-fixing antibodies are
generally short lived, with their titers diminishing rapidly between 6 and 12 mo from
onset at the end of which period most sera are negative; on the other hand, neu-
tralizing antibodies remain detectable for years (40, 43). Lassa fever having been
recognized only within the last few years, no information is available on antibody
persistence.
Antibodies have been detected in persons in whom no specific diagnosis had been
made, perhaps having had only a subclinical infection, particularly with LCM (1,
14); the current view is that clinically inapparent infection is rare with Junin and
Machupo viruses (40).
VI. LYMPHOCYTIC CHORIOMENINGITIS
LCM virus was first isolated in 1933 in the course ofinvestigations on the etiology
of an epidemic of encephalitis in St. Louis, MO (8); the virus may have been present
in the CNS tissue of a patient who died of that illness or, more likely, derived from
monkeys inoculated during the study. An etiological association between the virus
and a disease of man, acute aseptic meningitis, was established (75, 83) by isolation
of the agent and demonstration ofdevelopment of antibodies. While at an early pe-
riod it was assumed that LCM virus was the exclusive etiological agent of acute
aseptic meningitis, or Wallgren's disease, it soon became apparent that the virus
caused only a small proportion of the cases. Traub (89) reported that a colony of
laboratory albino mice was chronically infected with a virus subsequently identified
as LCM; this finding was the beginning ofa new concept, persistent tolerant virus in-
fections, which has considerable epidemiological implications on LCM virus and
other arenavirus infections ofman.
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A. Descriptive Epidemiology
1. Incidence and prevalence. Determination of infection or illness caused by
LCM virus requires a laboratory-confirmed specific diagnosis; in general, this is not
attempted since the required laboratories are not always available. Efforts to obtain
a specific diagnosis usually require special circumstances, such as a large number of
clinically suspect cases appearing simultaneously (7); or the continuing interest of
groups ofinvestigators (Adair et al. (4); Meyer et al. (58); Blumenthal et al. (14)).
Soon after the discovery ofthe virus and its association with cases ofaseptic men-
ingitis it became clearly apparent that clinical infection of man due to LCM viru's
was a rare event; later surveys supported the view.
One of the most extensive surveys to determine the prevalence of clinical LCM
virus infection in man was conducted among USA military personnel and depen-
dents over an 18-yr period, from 1943 to 1960 (Adair et al. (4); Meyer et al. (58)).
Examination of nearly 1600 CNS illnesses revealed that only 8% were specifically
diagnosed as LCM infections; on the average seven cases a year occurred during the
entire period. No estimate can be made of undiagnosed cases or, if they existed, of
subclinical infections; a study in the USA (97) showed that 5% of about 1200 sera
from residents of various areas had neutralizing antibodies; it is conceivable that a
certain degree ofnonspecific inhibition ofvirus may have occurred in that study (43)
so that the results may not be specific.
Investigations in West Germany since 1960 (Ackerman et al. (2); Scheidt et al.
(81); Blumenthal et al. (14)) indicate the extent of the distribution of LCM virus in
that country and the close association between the incidence ofinfection of man and
the presence of virus in the mouse. Early observations by these investigators had
shown the rarity of the disease in a number oflargehospitals in the country; further-
more, antibody surveys with sera from selected individuals revealed only about 1%
ofpositives (1). In a subsequent survey (14) done after the distribution ofthe virus in
mice had been investigated, sera from about 2000 persons from rural districts were
tested for neutralizing antibodies; 68 of these sera, or 3.4% were positive; on the
basis ofthis survey Ackerman (1) estimated that as many as 1000 newinfections per
year may occur in a population of about 6 million persons in rural German areas;
since only a minute fraction ofthis number are clinically recognized, the inference is
that most LCM virus infections go undiagnosed or are subclinical.
2. Geographic distribution. The virus of LCM may well have worldwide dis-
tribution, being present in all parts of the world where the house mouse is found.
Well-documented proof ofthe virus presence has been given for European countries
and North and South America; its presence has also been reported in Asia, less con-
vincingly in Africa, and not in Australia (43).
3. Age, sex, and occupation. Since LCM is not usually reported, the effect of a
number ofvariables in its spread and prevalence is difficult to appraise. A seroepide-
miological report from West Germany (14) indicated that the distribution of anti-
bodies was not influenced by sex or occupation-whether farm work or professional
or office work; in that survey hardly any positives were found among persons under
20 yr of age. On the other hand, no influence of age was seen in hamster-related out-
breaks (3, 7). It is possible that mouse-associated infections are more common in
rural populations or in lower socioeconomic urban groups and that hamster-
associated cases are found, principally, in urban centers. Further, a seasonal fluc-
tuation ofcases has been suggested in man, more in winter than in summer. Perhaps
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this is associated with migratory habits of the house mouse (43) and possibly with
closer contact with mice in the cold months in the temperate zone.
Special attention should begiven to LCM as an occupational disease in laboratory
personnel, either in individuals who work with the virus or who work in other prob-
lems but who use animals-mice, hamsters, possibly monkeys-that may be
infected. Reported laboratory accidents may well represent only a fraction ofall the
occurrences; in the period between 1952 and 1966, 45 laboratory infections with five
deaths have been documented (87).
B. Mechanism andRoute ofTransmission
1. Spread ofvirus. The only known true carrier of LCM virus is the mouse from
which man becomes infected. Probably other species areimportant, particularly the
hamster, from which man also becomes infected. Man-to-man transmission seems
unlikely.
The mechanism of transmission from mouse to man cannot be stated with
certainty. It would appear that either the airborne route through household dust
contaminated with mouse urine and other excretions and secretions, or the contami-
nation of food and drink by the mouse excretions are the most likely sources of
human disease. The portal ofentry in these instances would be the upper respiratory
or, possibly, the upper digestive tracts; the possibility of transmission through skin
abrasions has also been considered.
While airborne transmission appears the logical mode ofhuman infection, accep-
tance of this hypothesis runs into problems represented by the known lability of
LCM virus under unfavorable conditions; however, no other explanation has been
put forward to replace airborne or food contamination. Transmission by an
arthropod vector has been investigated but the evidence is against it; it is worthwhile
to mention, however, that Aedes aegypti has transmitted the infection by bite to
monkeys 15 days after feeding on infected guinea pigs (20).
2. Reservoir. In nature, the virus in addition to man who is most likely a dead
end, has been isolated from various animal hosts. Chief among these, for epidemio-
logical implications including maintenance ofthe virus in nature, is the house mouse
(Mus musculus). In recent years, the Syrian hamster (Mesocricetus auratus) is
gaining importance as a source ofinfection ofman, ifnot as a true reservoir.
From the first demonstration ofLCM virus in house mice trapped in the home of
two persons suffering from nonbacterial meningitis, Armstrong and Sweet (9), the
abundance of isolations has left no doubt about the close association in nature be-
tween the virus and this rodent. Furthermore, it has been shown that experimental
mouse colonies can be chronically infected (90). Studies on the nature of the in-
fection oflaboratory mice by LCM virus extending over a period ofover 30 yr, have
clearly shown that the mouse infected in utero or within a few hours after birth de-
velops a tolerant persistent infection; mice thus infected circulate virus in their
blood, develop no antibodies, and they maintain an active and relatively normal
health condition for a period of time representing a good fraction of a normal
mouse's life span. The epidemiologically important feature ofthe tolerant persistent
infection is that wild mice so infected shed virus continuously for the duration of
their lives, by way of urine, feces, nasal and mouth secretions and excretions. The
virus thus excreted will contaminate the ambient in households, food, drink, dust,
fomites, from which, and by ways as yet undetermined, man becomes infected. In
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addition, new generations of mice become tolerantly infected at birth or in utero,
thus maintaining the carrier status of the mouse populations; and, in addition, mice
so infected may become the source from which other species-hamsters, guinea
pigs, monkeys-are infected and they, in turn may infect man.
The studies of Ackerman et al. (2) and Blumenthal et al. (14) are particularly
illustrative of the association between infection of mice and infection of man. Sixty-
five mice of 1795 trapped between 1960 and 1962 in 44 of 376 areas in West
Germany were LCM carriers, as shown by virus isolation; nearly all positive trap-
ping areas were in North and Northwest Germany, none in South Germany.
Serological surveys done at about the same time in which 1371 persons from rural
districts were tested by neutralization test showed that, of 511 sera from persons in
North and Northwest Germany, in or near the places where LCM virus had been
isolated from mice, 9.1% had antibodies. The second set of sera from 811 persons
were from South Germany where no LCM virus had been isolated from mice; only
5, or0.6%, werepositive.
In recent years, the Syrian hamster has emerged as an important source of
human infection and illness caused by LCM virus. Small outbreaks had occurred in
the past involving persons participating in biomedical research work in which
hamsters were used (Lewis et al. (45); Armstrong et al. (10)). Between 1968 and
1971, 47 LCM infections were described in West Germany. These were specifically
diagnosed by antibody detection as caused by LCM virus in persons who shortly be-
fore their illness had been in contact with pet hamsters; 45 of these infections were
clinical, mainly influenza-like or aseptic meningitis, and two had no clinical
manifestations (3). Subsequent investigations in West Germany (26) on commercial
breeding colonies showed that of 598 animals examined, representing 11 different
breeders, LCM virus was isolated from animals of six different colonies. According
to the authors ofthat study, it is estimated that close to 1 million hamsters are sold
annually as pets in West Germany; it is obvious that the importance of this animal
as a source ofinfection of man cannot be overlooked.
Two outbreaks ofLCM in man, associated with hamsters, have been recently ob-
served in the USA. Early in 1973 an episode occurred in a laboratory where
hamsters were used for cancer work (7). The investigation of the outbreak revealed
several interesting points. In all 21 persons became ill with a severe influenza-like
illness, ofwhich 14 had occurred before LCM infection was suspected. In addition to
the 21 clinical cases, confirmed by FAT antibodies, there were an additional 17
persons who had antibodies but no illness; in other words, inapparent infections oc-
curred. The association with hamsters was clearly seen in that 75% of20 persons ad-
mitting to have touched the hamsters were seropositive, while only 17% of 61
persons who had no contact other than entering the premises were positive; the lat-
ter may have been instances ofairborne infections. LCM virus was isolated from 11
of 24 hamsters tested. The animals appear to have been infected from virus present
in the tumor line with which they had been inoculated.
In another extended episode, 93 human cases in seven states were diagnosed, and
specifically confirmed, between December 1973 and April 1974 (25). The association
with pet hamsters was established in every instance; in some instances, two or three
cases occurred in a family. The diagnoses were established by FAT and CF tests, in
man and hamsters; it appears that of several breeders whose animals were tested,
only one had an infected colony.
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The episodes in the USA and Germany point to the importance ofhamsters as a
source of human infection with LCM virus; while this animal is not a true life-long
carrier, it can circulate and excrete virus for periods of2 or 3 mo after its infection.
There are additional animal species from which the virus has reportedly been
isolated in nature such as monkeys, guinea pigs, and dogs. The role that these
species play in virus dissemination to man is undetermined but it appears to be
unimportant.
C. Patterns ofHost Response
1. Clinical aspects. Infection of man by LCM virus presents different clinical
forms and there may be inapparent infections. Three major clinical forms seem to
prevail: aseptic meningitis, influenza-like or non-nervous system type, and menin-
goencephalomyelitic type (43). The influenza-like and meningeal are the most fre-
quent types. The incubation period is believed to be from 6 to 13 days. In the
influenza-like (or grippal) type there are fever, malaise, muscular pains, coryza, and
bronchitis; in the meningeal type, which is the commonest, there is a "grippe"-like
beginning followed by definite signs and symptoms of meningitis, with stiff neck,
headache, and nausea, which may remain mild and of short duration or can be
pronounced, last for 2 wk or longer, and lead to considerable prostration.
The great majority of specifically diagnosed, clinical infections follow a benign
course; only a few fatal cases have been reported, either after CNS involvement (4)
or after systemic generalized illness with hemorrhagic manifestations (84). Chronic
sequelae, although rare, have been reported, including paralyses, headaches, per-
sonality changes; it appears that the documentation of most such cases is am-
biguous (43).
2. Diagnosis. Clinical and routine laboratory analyses are indicative of only
aseptic meningitis: the CSF is under increased pressure, with slightly increased pro-
tein, normal or slightly reduced sugar, and moderate number of cells, from 150-
400/mm3.
The virus in man can be isolated from blood, CSF, and, in fatal cases, from brain
tissue. The best sources for isolation are blood during the febrile period and CSF
during the period of meningeal manifestations; virus can be isolated from the blood
and CSF from experimentally infected man for 20-25 days (13).
The animal of choice for virus isolation is the laboratory albino mouse, 3-5 wk
old; after intracerebral inoculation the incubation period and signs of illness are
nearly pathognomonic. Care must be taken to use mice from a colony known to be
free from the virus. Inoculation of cells in cultures could be used since most cells
support replication of LCM virus; however, since virus replication in general does
not cause CPE or plaques, detection ofviral antigen in the cells must be made by CF
or FAT tests.
The techniques employed for detection of antibody development are the CF and
the indirect FAT tests; it has been reported that the latter appears earlier than CF
antibody (35). In recent investigations of antibody determination in man and
hamsters, there has been nearly complete agreement between the results of these
two tests (Woodall, personal communication, 1974). Neutralizing antibodies appear
much later after onset; therefore, the neutralization test is not helpful for an early
diagnosis; it is most profitably used in serum surveys (14).
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D. Treatment andPrevention
There is no specific treatment advocated; in view of the definite association with
mice, it would appear that rodent control may minimize the risk. Monitoring of
hamster colonies for presence ofvirus and/or antibodies would beindicated.
VII. ARGENTINIAN HEMORRHAGIC FEVER (AHF)
A disease resembling AHF and with the samegeographical location seems to have
been first recognized in 1943 (72). Arribalzaga (11) gave the first detailed account of
the disease and considered it a new nosologic entity; his description included ex-
tremely accurate clinical and epidemiological observations. The causal agent, Junin
virus, was isolated in 1958 (66, 73). Annual outbreaks of the disease have occurred
since 1958 and the endemic zone has been progressively increasing in area.
A. Descriptive Epidemiology
Collection ofdata concerning clinically diagnosed cases ofthe disease and labora-
tory efforts to confirm the clinical diagnosis, appear to be efficiently done through
local, provincial, and national Public Health centers in Argentina (21, 72).
1. Prevalence in man. AHF is predominantly a rural disease that affects adult
males with agricultural occupations, particularly harvesting ofmaize; 80% ofnearly
1000 cases recently analyzed were in males and 63% ofthe total number were in the
agegroup between 20 and 49 yr (Maiztegui (49); and personal communication).
2. Geographic and seasonal distribution. The endemoepidemic zone was first
recognized in the northwest of Buenos Aires province; by 1958 its area was esti-
mated at 16,000 km2. Since that year the zone has spread west and north, to include
additional localities in Buenos Aires as well as sections of two adjacent provinces,
Cordoba and Santa Fe; the affected area was estimated in 1970 to be 80,000 km2 in
which lived a population of800,000 persons (79). The total number ofcases reported
from 1958 to 1972 is about 13,000, with annual fluctuations between 100 and 3500;
the mortality among laboratory-confirmed cases studied at Pergamino has been
from 10 to 20% (Maiztegui (49); and personal communication).
The disease is sharply seasonal with the outbreaks beginning late in summer (Feb-
ruary), reaching a peak in autumn (May), and ending early in winter. The seasonal
distribution coincides with the intensification of agricultural labors, particularly
harvest of maize, and with an influx of transient farm workers; at the same time
there is an increase in the population ofwild rodents, which are considered the prin-
cipal reservoir of the virus. While overwhelmingly a rural disease, cases of AHF
have been observed in an urban setting in the near absence of the main reservoir
(Calomys) of the virus (Maiztegui et al. (51); Sabattini and Maiztegui (79));
however, the simultaneous existence of LCM and Junin virus in an area may create
diagnostic problems (50).
B. Mechanism andRouteofTransmission
1. Spread to man. Chronic infection ofrodents with associated viruria is the basic
mechanism of transmission of the virus to man; there is no evidence implicating
arthropod transmission (40, 79). The mode of transmission from wild-infected
rodents to man has not been definitely established. It may be airborne from dust
contaminated by the excretions or secretions from rodents; or by the oral route
through ingestion of food and drink equally contaminated. Since the disease has
been transmitted to human volunteers by injection (73), it may be possible that the
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disease is also acquired through skin abrasions in the course of farm work while han-
dling materials contaminated with rodent's excreta.
Although the virus has been isolated from throat swabs and urine from patients,
contact transmission between individuals is exceptional (78).
2. Reservoir. The possible connection between wild rodents and AHF was first
stated by Arribalzaga (11). Accumulated observations beginning in 1958 support the
close association between disease and rodents in the endemic areas. The main
reservoir are two species of Cricetidae, Calomys laucha and C. musculinus, which
are present in farm fields and along hedgerows, the latter species predominating in
Cordoba province (79); Junin virus has also been isolated from Akodon, Azarae,
and, rarely, from Mus musculus (21). Field and laboratory investigations show that
Junin virus causes a chronic tolerant infection in C. musculinus with persistent vi-
remia and viruria and no development of antibodies (79); most likely, the virus is
maintained in nature by infection ofthe rodents at birth. Although the virus has been
isolated from mites (68, 73), it has not been established that they play a role in trans-
mission between rodents or to man.
C. Patterns ofHost Response
1. Clinical features. The disease presents a syndrome that includes manifesta-
tions of renal, cardiovascular, and hematic involvement; pronounced neurological
manifestations are also described, but not frequently. The disease lasts from 7 to 14
days and terminates with either complete recovery with no sequelae or with death.
After an incubation period estimated at from 7 to 16 days there is an insidious and
gradual onset with chills, asthenia, malaise, headache, retro-ocular pain, muscular
pains, often pronounced in the costovertebral angle, anorexia, nausea, and vomiting.
The most prevalent signs at the outset are fever with temperatures up to102-104° F,
conjunctival injection, enanthem, exanthem on face, neck, and upper thorax, a few
petechiae particularly in the axilla, polyadenopathy, and muscular tenderness at the
thigh. Three to five days after onset the signs and symptoms become more
pronounced in the severe cases, with dry tongue, dehydration, oliguria, hypotension,
relative bradycardia and, in the worse cases, hemorrhages from the gums, nasal
cavities, also hematemesis, hematuria, and melena; oliguria may develop into
anuria. In the severe cases there are psychosensorial and motor alterations. Death is
due to uremic coma or hypotension and hypovolemic shock due to plasma leakage,
not whole blood loss. In nonfatal cases the fever diminishes by lysis, there is marked
diuresis and rapid improvement within days; however, convalescence is prolonged.
The case fatality rate has been as high as 20%; usually it is between 3 and 15% in
different outbreaks. Clinically inapparent infections appear to be very rare (55, 79,
37).
2.Simultaneous occurrence of AHF and LCM. Investigations in areas of the
AHF endemic zone to determine the source of virus in an urban setting (52) led to
the finding of antibodies against LCM virus in mice (M. musculus); at about the
same time a strain of LCM virus was isolated from that species (80). A re-exami-
nation of antibodies in acute and convalescent sera from nearly 3000 cases of AHF,
using LCM and Junin antigens, revealed that in a substantial number of instances,
AHF occurred in persons who showed evidence of previous infection with LCM
virus (49). Furthermore, there were a few cases previously diagnosed as AHF in
which the serologic diagnosis was changed to LCM (49). Additional evidence of the
activity of LCM virus in the endemic AHF area is given by the simultaneous ad-
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mission to a hospital oftwo agricultural workers with clinical diagnosis ofAHF, but
with specific serological conversions to Junin virus in one, to LCM virus in theother
(50).
Since only between 60 and 70% ofpatients clinically diagnosed ashaving AHF are
generally serologically confirmed, it had previously been suspected that other agents
were active in the endemic area in epidemic times; serological evidence of infection
with group B arboviruses has been reported (54) in a number of persons diagnosed
clinically as AHF cases and from one, St. Louis encephalitis virus was isolated (56).
3. Diagnosis. Clinical diagnosis of AHF has been confirmed either serologically
or by virus isolation in from 60 to 70% of reported cases (55). In a thorough study
involving 2249 reported cases over the period 1965-1972, in the city of Perganino,
the diagnosis was confirmed in 62% and was doubtful in 11% of cases (Maiztegui
(48,49) ).
During the epidemic season of AHF, there appear to occur in the same areas
other diseases of viral etiology which at the early phase present clinical manifesta-
tions similar to AHF (Schwarz et al. (82); Mettler (54) ). A study of signs and
symptoms in a number of patients clinically diagnosed as having AHF, in whom
laboratory confirmation was sought, showed that during the first week of illness a
combination ofasthenia, dizziness, petechiae in the axillary region or anterior chest
wall and conjunctival congestion was present in 71% of confirmed cases, only in
3.5% of nonconfirmed ones. When in addition are found leukopenia, thrombocyto-
penia, and casts in the urine, thediagnostic accuracy is further increased (82).
Specific diagnosis is based on isolation of virus or demonstration of serological
conversion. The virus is isolated from the blood during the acute period, probably
from the 3rd to the 10th day after onset; and, in fatal cases, from liver, spleen,
kidney and clotted blood. The materials are intracerebrally inoculated to newborn
mice, 1-3 days old; or to guinea pigs by peripheral or intracerebral route. While
Junin virus replicates with CPE in several cells in culture, little has been reported on
the use oftissue cultures for isolation ofthevirus from nature (79).
The test of choice for demonstration of antibodies is the complement-fixation
test; AHF shares with other diseases caused by arenaviruses the characteristic that
complement-fixing antibodies develop relatively late after onset; an early sample
and a second one taken not before 30 days after onset seem to offer the best possi-
bility to detect serological conversion.
Recent developments (Oro et al. (65); Maiztegui (49)) have shown the si-
multaneous development ofCF antibodies against Junin and LCM virus antigens in
patients in the AHF endemic zone, clinically diagnosed as cases of AHF, including
some from whom Junin virus was isolated from acute-phase blood. This fact creates
serious difficulties for reaching a definite diagnosis, not heretofore encountered with
other arenavirus infections ofman; as a result, epidemiologic evaluation ofdata may
be faulty.
D. Treatment, Control, andPrevention
There is no recommended specific treatment; administration of serum from
recovered individuals has not been generally used. Vaccination ofthe exposed popu-
lation has been advocated; however, there is no available vaccine. Efforts to develop
a vaccine employing an attenuated strain ofJunin virus have been reported; adminis-
tration ofthe preparation to a small number ofpersons on an experimental basis led
to thedevelopment ofantibodies with only relatively minor febrile reactions (67).
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Ecological control to reduce the number ofrodents and exposure of man to them
appears difficult to implement. The circumstances under which the bulk of the ex-
posed population live and work at the time ofthe harvest will not be likely to change
in the near future; increased mechanization of farm labors and improvement of
housing conditions would, undoubtedly, reduce morbidity (21).
VIII. BOLIVIAN HEMORRHAGIC FEVER (BHF)
Thedisease was first recognized in 1959 in two rural areas in the northeastern part
of Bolivia, Department of Beni. Late in 1962 and early 1963 cases began to appear in
a nearby town, San Joaquin, developing into a large outbreak that continued until
the middle of 1964; nearly 700 persons were ill with a mortality of 18%. The disease
has continued to appear in the Department of Beni more or less annually in sharply
localized outbreaks (37, 40, 46). An outbreak which occurred in 1971 in
Cochabamba, Bolivia (40) differed ecologically from previous ones and represented
an extension ofthevirus to a new area.
A. Descriptive Epidemiology
1. Prevalence in man. Before 1962 the small outbreaks affected mainly adult
males and most cases occurred from April to September, which is the time of
highest agricultural labor. From 1963, when the disease appeared in towns and
villages and larger numbers of persons sickened, the pattern changed. Adult males
still presented somewhat higher rates of morbidity, but all persons were affected
with little relation to sex, age, and occupation; it was soon apparent that the disease
was "house-associated" with the lower socioeconomic groups experiencing the hi-
ghest incidence of disease. Although a seasonal pattern is evident, with the highest
incidence from February to September, cases occur in each month (46, 37).
2. Geographic distribution. The main epidemic centers, San Joaquin and Oroba-
yaya, are located in the Department of Beni, in the northeastern section of Bolivia;
these centers are on an immense flat plain east of the Andes. The prevailing
vegetation type is that of a grassland broken with "islands" offorest and numerous
tree-lined rivers and streams (Kuns (42) ). The human settlements where cases have
occurred in the past were on slightly elevated sites that generally escape flooding
during the heavy rains; the houses are on the edge of the forest, overlooking the
grass-covered marsh lands. These villages and settlements are heavily infested with
Calomys callosus, a mouse-like rodent which, although pastoral, readily invades and
lives in houses in a manner similar to thehouse mouse, Mus musculus (42).
B. Mechanism andRouteofTransmission
1. Spread to man. Transmission from rodent to man is probably by contami-
nation of food, water, or air with infected rodent urine or by inoculation through
skin abrasions (40). Human-to-human transmission can occur in rare cases ofclose
contact (22), but it is not considered important in the spread ofthenatural infection.
There may be, however, circumstances that promote such type of transmission, as
shown in a relatively recent small outbreak in Cochabamba, Bolivia, which is outside
the habitat ofCalomys callosus; from an index case, who had acquired the infection
in the endemic area, five secondary cases developed including family and medical
personnel; all were fatal except one (40).
2. Reservoir. The distribution of cases in a town in the form ofclusters definitely
associated with certain houses, the absence of evidence of human-to-human trans-
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mission and the equally negative evidence of an arthropod vector, led to the in-
ference that a reservoir may be involved that lived in or near households; soon the
association of disease with a rodent, Calomys callosus was firmly established. This
rodent has been trapped in all households where cases have occurred; houses which
were located in sites which did not favor the presence of this rodent, were spared;
finally, the dramatic termination of the epidemic in San Joaquin in June 1964, 2 wk
after continuous trapping ofC. callosus had been implemented left littledoubt about
the association (42, 46). Fifty percent of C. callosus caught wild at the time of that
epidemic were infected with the virus (38); experimental studies with colonized
Calomys show that on inoculation of Machupo virus the rodent develops a tolerant
infection with persistent viremia and viruria and no development of antibodies (41).
Calomys are easily infected by oral and nasal routes, and also by contact with
infected cage mates; about 50% develop viremia and viruria for life (39).
All efforts to isolate the virus from arthropods caught in the epidemic area at the
epidemic time have been negative (42).
C. PatternsofHost Response
1. Clinical features. The disease is clinically so similar to AHF that a joint
description is often given (36, 37). The incubation period is estimated at from 7 to 14
days. The onset is insidious, and the fever, which has been carefully monitored in nu-
merous etiologically confirmed cases, reaches a temperature between 102 and
105° F, with little diurnal variation, remaining at that level for at least 5 days. About
30% of the patients present hemorrhagic manifestations consisting ofpetechiae on
the upper part of the trunk and oral mucous membranes and on occasion, bleeding
from gums, nose, stomach, intestines, and uterus; blood loss is, however, not a
threat to life (40). Nearly half the patients exhibit a fine intention tremor of tongue
and hands beginning 4 or 6 days from onset; about one-fourth ofthese may develop
a frank and extensive neurological course. Somnolence and coma are hardly ever
seen, except in very young children. The acute disease can last for 2-3 wk; conva-
lescence is long, with complaints of severe generalized weakness and manifestations
of autonomic dysfunction. Probably owing to the continuously elevated temper-
ature, loss ofhair and transverse grooving ofthe nails is common. The mortality has
varied depending on outbreaks from 5 to 30%; clinically inapparent infection is very
rare.
2. Diagnosis. The clinical diagnosis by an experienced physician, in the endemic
area and in moderately severe or severe cases, is fairly accurate; because of the toxic
condition ofthe patient, BHF may resemble typhus or typhoid fever. Certain clinical
laboratory data help the clinician: leukopenia, thrombocytopenia, and increased
hematocrit; the latter indicates a poor prognosis (40).
A specific diagnosis is based on virus isolation or development of antibodies. The
most successful animal for virus isolation has been the newborn hamster, inoculated
by the intracerebral or intraperitoneal routes. Recovery of Machupo virus from
acutely ill patients is, however, quite difficult; only one in five samples, mostly sera,
from serologically confirmed cases yielded virus, most frequently between the 7th
and 12th day after onset. Virus is rarely isolated from urine or throat swabs. In fatal
cases, on the other hand, virus is easily and generally isolated from spleen and lymph
nodes (37).
The most convenient and efficient means for establishing a specific diagnosis is the
CF test. While this test is group specific rather than type specific, no diagnostic
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problems have arisen with Machupo virus due to its sharply localized geographical
location. As with other diseases in this group ofviruses, CF antibodies are relatively
late in appearing; although they have been found on the 14th day after onset, it is
advisable to test a sample ofserum between 40 and 60days after onset (46, 47).
D. Treatment, Prevention, andControl
Administration of convalescent plasma has been advocated and used. In spite of
some impressions of favorable clinical responses, its efficacy has not been es-
tablished or denied, owing to insufficient observations (36).
Rodent control by continued trapping has been the most effective single means for
preventing human infection and for terminating an epidemic; this approach,
however, seems unlikely to be the long-term solution of the problem. Given the
sharply localized geographical distribution of the disease, it would seem that vacci-
nation of exposed populations would be the effective answer, but no vaccine is
available. Attenuation of a strain of Machupo virus by serial intracerebral passage
in suckling mice has been reported and its possible use as source for a vaccine sug-
gested (40).
IX. LASSA FEVER
The disease was first observed in 1969, in a missionary nurse stationed at a lo-
cality in northeastern Nigeria; after her admission to a hospital in Jos, Nigeria, two
contact cases developed in nurses at that hospital (27). Owing to the circumstances
surrounding this outbreak and to the fact that two ofthe threepersons affected died,
the disease acquired from the outset a reputation for severity which subsequent
events amply justified. In addition to the initial episode, four more outbreaks have
occurred between 1970 and 1974 in Nigeria, Liberia, and Sierra Leone (17, 28, 61);
furthermore, laboratory accidents haveoccurred in the USA (12, 44).
1. Geographic distribution. The disease has been observed in several localities in
Nigeria (Lassa, 1969; Jos, 1970; Onitsha, 19742), in Liberia(1972), and Sierra Leone
(1970-72). The number ofcases seen, or retrospectively diagnosed, in the outbreaks
has varied from three to slightly over 60. Retrospective serological surveys have
demonstrated the existence of Lassa virus infection in Guinea (34) and Central Af-
rican Republic (Frame andCasals, unpublished).
2. Epidemic types: Season, age, and sex distribution. Two types of outbreaks
have been observed. The first type, hospital associated, develops as a result of ex-
posure and spread from a hospitalized index case to other patients, visitors, and
medical staff. The index case usually acquires the infection in the nearby com-
munity; between 10 and 20 days after admission to the hospital a cluster of sec-
ondary cases develops (17, 27, 61). This type ofoutbreak has been the rule with one
exception.
The second type ofoutbreak ofwhich there is at present only oneexample (Sierra
Leone, 1970-72), occurs in the community at large. Patients acquire their infection
at home or other community surroundings, rather than by exposure or contact in
the hospital with another patient. However, there is also possibility of nosocomial
transmission in this typeofoutbreak, particularly to thehospital staff(28).
Tertiary cases have been recorded but with a few exceptions, notably by trans-
mission to medical staff, they have been milder. No evidence has been reported of
further propagation ofthedisease (17).
2Information relative to the episode in Onitsha was supplied by Dr. E. A. Smith, Federal Ministry of
Health, Lagos, Nigeria and Dr. Allan S. Noonan, Smallpox Measles Program/CDC, Lagos, Nigeria.
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The mortality in hospitalized cases has been between 30 and 66% in different out-
breaks, with an average of 36%. The mortality after infection, however, appears to
be much lower. In the Sierra Leone focus many persons were found with antibodies
who either had not been ill or possibly remembered a mild disease; the over-all
mortality from Lassa virus infection in that area may have been only 3-5% (28).
There is a seasonal distribution ofhospital-associated outbreaks, which have oc-
curred from January to April, during the dry season; the Sierra Leone cases oc-
curred through the year with somewhathigher incidence in the wet season.
With respect to age and sex distribution, the Sierra Leone outbreak with its pat-
tern of transmission in the villages revealed no important predilection in morbidity
or in case-fatality rates (28). In the hospital-associated outbreaks, the distribution,
by sex and age, was determined largely by the characteristics of the exposed popu-
lation; physicians and nurses have been particularly affected.
B. Mechanism andRouteofTransmission
1. Spread of virus. The transmission in a hospital setting is undoubtedly from
person-to-person by either the contact or the airborne routes, including direct
contact, droplet spread, sharing of drink, food, clinical instruments, objects, and
utensils. The same mode of transmission may be at work in contact infections ac-
quired in the home.
In the community-centered outbreak at Sierra Leone there wasdefinite clustering
of illness and seropositivity without illness in certain households; this could be ex-
plained either by multiple instances of human infection from the same natural
source, or by person-to-person transmission after a house index case who had ac-
quired the infection from the reservoir (28).
The mode of transmission to man from the natural source or reservoir-a
rodent-is still unknown: it may includedirect contact with the rodent and its excre-
tions and secretions; eating ofuncooked rodent's flesh; contact with food and drink
contaminated by the rodent; and it could also be airborne. The possibility of an
arthropod vector appears extremely remote to explain transmission to man.
Whether ectoparasites can transmit the infection between rodents is not known.
Penetration through a cut while performing an autopsy appears to have been the
mode of infection of a physician (94); and infection through a cut on a finger may
have occurred in a nurse (27). Most medical and nursing personnel probably acquire
the disease by droplet infection, since it has been established that thevirus is present
in the throat washings ofpatients for several days (15, 44, 60).
2. Reservoir. Certain similarities between Lassa fever and thediseases caused by
other arenaviruses, as well as theobservation that Lassaviruspersists for monthsin
the urine ofexperimentally infected laboratory micewhich appear otherwisehealthy
(15), support theview that this virus may have a rodent reservoir in nature.
Small wild vertebrates collected in the course of investigating the Sierra Leone
outbreak, 1970-72, focused attention on rodents and bats, since these hosts are im-
plicated in the ecology of other arenaviruses. Pooled tissues of heart, lung, spleen,
and kidney from 325 field specimens tested for the presence of virus revealed only
one infected species, Mastomys natalensis. This yielded 10 viral isolations in 46
specimens tested (6). This species is common and widely distributed in sub-Saharan
Africa. In addition to its wild habitat, it is often peridomestic, entering houses and
other buildings; the potential for human contact is considerable.
Additional information is required in order to settle the question of the reservoir
of Lassa fever virus, particularly whether other vertebrate species areinvolved in the
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natural cycle. More study is also needed on the dynamics of Mastomys natalensis
population and its ecology.
C. Patterns ofHost Response
1. Clinicalfeatures. Lassa fever is a disease with generalized organ involvement
manifested in severe cases by pharyngitis, pneumonitis, myositis, myocarditis,
encephalopathy, nephropathy, and hemorrhagic diathesis. The over-all spectrum of
infection of man is not yet fully known; therefore, it is not possible to estimate the
risk of severe illness after infection with the virus. All earlier reports (17, 27, 61, 94)
stressed the severity of the disease; however, there is evidence of milder forms,
perhaps even inapparent infections (28).
The incubation period is ordinarily between 6 and 14 days. The disease has an
insidious onset; in variable order appear malaise, asthenia, lassitude, headache, sore
throat, muscular aches, abdominal pains, loss of appetite, nausea, vomiting, and
diarrhea. Fever appears early with somnolence, indifference, and blurred vision; the
temperature is in the range of 101-104° F, and may reach 1070 F. Petechiae may be
seen, although the disease is not severely hemorrhagic. There is marked pharyngitis
with firmly adherent white patches on the soft palate, pharynx, and pillars. In
severe, progressive forms signs of increase in capillary fragility appear with a
suffusion or flush on the skin of face and upper thorax, puffed face, swollen neck,
markedly blurred vision. There is increased oliguria and dysuria. Additional pete-
chiae appear and sometimes larger subcutaneous hemorrhages on the arms, legs,
and abdominal walls. Pleural effusions may also occur. The acute febrile stage lasts
from 7 to 21 days; in fatal cases death occurs usually during the course ofthe second
week, its immediate cause being sudden cardiovascular collapse. The death rate in
hospitalized cases has been from 30 to 66%, over-all about 36% (17, 27, 44, 61, 94).
2. Diagnosis. Lassa fever, unlike the other arenavirus infections, has a marked
tendency to spread by human-to-human contagion. Under these circumstances
prompt diagnosis is essential in order to implement strict isolation measures. In the
affected geographic areas a clinical diagnosis is complicated by the occurrence of
other diseases which may resemble Lassa fever. Theseinclude malaria, yellowfever,
and especially typhoid fever. The lack oflocal laboratory facilities makes a specific
diagnosis unavailable. In endemic areas an illness characterized by unremitting fever
with temperatures of 100° F or higher, persisting for 5-7 days or more, unresponsive
to antibiotics and antimalarial drugs, accompanied by pharyngitis, malaise, toxic
appearance, leukopenia and later, by facial edema, must give rise to a strong suspi-
cion ofLassa fever (56).
A specific diagnosis is achieved by isolation of the virus, demonstration of anti-
body development, or both. Virus is isolated from the blood between the 3rd and
14th day of illness (15, 60), less frequently from throat washings, pleural effusions,
and urine. Due to the recognized danger inherent in handling the virus, work with it
including attempts to isolate it are restricted to laboratories with special high con-
tainment facilities. Development ofCF antibodies between early and late samples of
sera is a useful diagnostic procedure which can bedone with inactivated noninfective
antigens (15); but it is no help for an early diagnosis since the antibodies do not
usually appear until 18 or 20days after onset.
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D. Treatment andDisposition ofPatients
Plasma from recovered cases has been used in a limited number of instances,
perhaps five or six. The number is not large enough to support any conclusions;
nevertheless, it appears that its effect has been favorable (44, 60), although in one
instance it failed to prevent a fatal outcome (94).
In view ofthe frequency with which the Lassa virus is propagated from person to
person in a hospital setting, strict measures must be instituted in order to isolate
patients and suspected cases. This includes the use ofgloves, masks, and gowns by
the staff, individual rooms for suspected cases, thorough decontamination ofexcre-
tions and secretions, and sterilization ofinstruments, bedpans, and personal utensils
(59).
Evacuation and international transportation ofpatients suspected ofhaving Lassa
fever presents a serious problem to public health officials, which is still largely unre-
solved.
E. Prevention and Control
Prevention at the individual level is based on strict sanitary precautions; no vac-
cine is available. Since M. natalensis is, thus far, theonly known reservoir, measures
that minimize contact of this rodent with man and his habitat will be helpful.
However, it is unrealistic at this time to base too much hope on the effectiveness of
the control ofthis rodent in theendemic areas.
X. UNRESOLVED QUESTIONS
A. Vaccines
With the exception of LCM virus which appears to have world-wide distribution,
the other arenavirus diseases of man have been found restricted to definite
geographic areas which, although showing a tendency to increase, are still easily
identifiable. In the case of Lassa virus, although the areas are multiple and possibly
more extensive than now known, they are confined to one continent. These
geographic considerations added to the fact that some of the more exposed
groups-maize harvesters for AHF and hospital personnel for Lassa fever-are well
defined, make these diseases an excellent target for preventive vaccination. Control
ofthe reservoirs would undoubtedly be effective in preventing disease or reducing its
incidence. At the moment, however, it does not appear to be a realistic solution.
Investigations to develop a vaccine for AHF have been carried out to the point
where a large number ofvolunteers have been inoculated with an experimental vac-
cine. Efforts to develop an attenuated strain of Machupo virus have been initiated.
No attempts to develop a vaccine against Lassa fever virus have been thus far
reported. In view of the severity of these diseases, continued efforts to develop safe
and effective vaccines aredesirable.
B. Early Diagnosis ofLassa Feverand Evacuation ofPatients
The frequency with which hospital-centered outbreaks have followed admission of
an undiagnosed Lassa fever case is a paramount reason for an early diagnosis; no
such urgency generally applies to the other arenaviruses. Detection of the de-
velopment of antibodies is not the answer since positive CF tests are exceptional be-
fore the end of the third week ofillness. Currently, the fastest way ofestablishing a
specific diagnosis is isolation ofthevirus in Vero cells in culture and identification by
135JORDI CASALS
the CF test. At the very best 6 days are required from the moment the specimen
reaches the laboratory. Furthermore, there is only one laboratory at this time with
the safe facility in which to conduct isolation attempts: The Center for Disease Con-
trol, Atlanta, Georgia. Even under optimal circumstances, by the time a presump-
tive diagnosis is confirmed the index case may have already infected a number of
persons. The possibility of applying the fluorescent antibody technique to throat
washings' smears or to smears of pelleted virus in a sample of serum should be
investigated.
Transportation of suspected Lassa fever cases should be reduced to a minimum
compatible with good medical and nursing care. Evacuation and international trans-
portation of expatriate personnel suspected of having Lassa fever cannot be denied
to the individual. However, it presents a serious problem to national and interna-
tional health authorities whose responsibility is to localize the infection and prevent
its spread to other areas.
C. Hemorrhagic Fever with RenalSyndrome
This disease is known by numerous synonyms among which are hemorrhagic
nephroso nephritis and Korean hemorrhagic fever. It has a number of clinical and
epidemiological characteristics similar to those seen with arenavirus infections. It
appears to be caused by a virus, on the basis of investigations carried out with
human volunteers by Smorodintsev and associates in 1940-41 (85) in the Soviet
Union, and by Kitano and associates in Manchuria at about the same time (29). The
etiological agent has not been clearly maintained in a laboratory host, although its
propagation in tissue cultures and identification by the fluorescent antibody tech-
nique has been reported (31).
The disease is prevalent in several sections of the USSR, principally in the Far
East and in the middle Volga region, Bashkiria; between several hundreds and
several thousands of cases occur annually (18, 19). The disease also occurs in Korea,
where in the period 1950-52 it affected several thousands of United Nations military
personnel, particularly Americans; the same, or very similar syndrome, occurs in
Sweden and has been reported in Hungary.
Clinically the disease has a prodromal stage, followed by sudden onset with chills,
fever, lethargy, frontal or retro-orbital headache, myalgias, costovertebral pain,
suffusion of face and upper part ofthorax, petechiae or larger skin hemorrhages and
pronounced renal involvement with proteinuria, oliguria, that may end up in anuria,
and low fixed specific gravity of the urine; there is leukopenia and thrombocyto-
penia. Death is associated with shock and occurs in a variable proportion of cases,
from 1-2 to 25-30%; the death rate is higher in the Far East than in the European
part ofthe USSR (18, 19, 29).
Extensive epidemiological investigations in the USSR appear to have established
a definite link including season, place, occupation, and exposure-between disease
and contact of man with various rodents, chief among them being Clethrionomys
glareolus, Apodemus sylvaticus, A. agrarius and Microtusfortis (18). Soviet investi-
gators consider that the rodents suffer a tolerant, persistent infection, excrete virus
in the urine, and thus contaminate the human habitat. Support for the view that
rodents are a reservoir of the disease agent is given by outbreaks in laboratory
personnel who were in contact with collections ofwild-caught rodents (91).
Only when the etiological agent of this disease is established in a laboratory host
or system will it be possible to investigate its properties and determine its relation-
ship with the arenaviruses.
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